Patents by Inventor Edoardo GAUDE

Edoardo GAUDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING LARGE VESSEL OCCLUSION STROKE
    Publication number: 20230393154
    Abstract: The invention relates to the diagnosis of stroke resulting from occlusion of one or more large vessels in the brain, and in particular to the diagnosis of stroke resulting from occlusion of one or more large vessels in the brain using one or more biomarkers.
    Type: Application
    Filed: June 1, 2023
    Publication date: December 7, 2023
    Inventors: Edoardo Gaude, Gonzalo Ladreda Mochales, Marcos Ladreda Mochales
  • Method of treating large vessel occlusion stroke
    Patent number: 11726100
    Abstract: The invention relates to the diagnosis of stroke resulting from occlusion of one or more large vessels in the brain, and in particular to the diagnosis of stroke resulting from occlusion of one or more large vessels in the brain using one or more biomarkers.
    Type: Grant
    Filed: September 22, 2022
    Date of Patent: August 15, 2023
    Assignee: POCKIT DIAGNOSTICS LIMITED
    Inventors: Edoardo Gaude, Gonzalo Ladreda Mochales, Marcos Ladreda Mochales
  • METHOD OF TREATING LARGE VESSEL OCCLUSION STROKE
    Publication number: 20230048418
    Abstract: The invention relates to the diagnosis of stroke resulting from occlusion of one or more large vessels in the brain, and in particular to the diagnosis of stroke resulting from occlusion of one or more large vessels in the brain using one or more biomarkers.
    Type: Application
    Filed: September 22, 2022
    Publication date: February 16, 2023
    Inventors: Edoardo Gaude, Gonzalo Ladreda Mochales, Marcos Ladreda Mochales
  • Method To Evaluate Metabolic Activity Of Liver Enzymes
    Publication number: 20220228192
    Abstract: The invention provides a breath test for assessing a metabolic phenotypeand/or assessing a disease state.
    Type: Application
    Filed: May 17, 2019
    Publication date: July 21, 2022
    Inventors: Edoardo Gaude, Max Allsworth, Marc van der Schee
  • DIAGNOSIS OF CANCER
    Publication number: 20210341461
    Abstract: A method for the early detection and monitoring of the progression of cancer by detecting breath biomarkers is provided. The method comprises assessing the activity of an aldo-keto reductase by measuring the concentration of an exogenous substrate for said enzyme and/or measuring the concentration of a metabolite of said substrate in exhaled breath of a subject. Preferably, the cancer is lung cancer.
    Type: Application
    Filed: September 4, 2019
    Publication date: November 4, 2021
    Inventors: Max ALLSWORTH, Edoardo GAUDE, Marc van der SCHEE
  • HUMAN ASPARAGINASE LACKING GLUTAMINASE ACTIVITY
    Publication number: 20190209665
    Abstract: The invention relates to a human asparaginase comprising an amino acid sequence that is at least 90% identical to the amino acid sequence depicted in Figure, for use as a medicament. Said asparaginase was found to lack intrinsic glutaminase activity. The invention further relates to a membraneous particle comprising said asparaginase, and to a pharmaceutical composition comprising said asparaginase and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: September 19, 2017
    Publication date: July 11, 2019
    Inventors: Stefano PLUCHINO, Christian FREZZA, Edoardo GAUDE, Tommaso LEONARDI, Nunzio IRACI